-
Covaxin gets emergency use approval for kids aged 2-18 years
For final clearance, the recommendations have been sent to the Drugs Controller General of India (DCGI).
-
Phase 2 and 3 trials of paediatric Covaxin completed
For ramping up production of Covaxin, Bharat Biotech has collaborated with Indian Immunologiclas and Hester Biosciences
